Stage IIIB Cutaneous Melanoma AJCC v7 Recruiting Phase 2 Trials for Acetylsalicylic acid (DB00945)

IndicationStatusPhase
DBCOND0091048 (Stage IIIB Cutaneous Melanoma AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03396952Prostaglandin Inhibition and Immune Checkpoint Blockade in MelanomaTreatment